Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 341,269 |
|
|||||
| News | - | ||||||
| Day High | 168.455 | Low High |
|||||
| Day Low | 164.46 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Repligen Corp | RGEN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.92 | 0.56% | 166.58 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 165.66 | 164.46 | 168.455 | 166.58 | 165.66 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,993 | 341,269 | US$ 167.01 | US$ 56,996,493 | - | 110.45 - 211.13 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:03:06 | 1 | US$ 163.30 | USD |
Repligen Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.29B | 55.77M | - | 669.33M | 41.58M | 0.75 | 223.39 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Repligen News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 157.63 | 174.30 | 154.87 | 165.94 | 480,913 | 8.95 | 5.68% |
| 1 Month | 184.98 | 184.98 | 152.19 | 169.83 | 486,909 | -18.40 | -9.95% |
| 3 Months | 190.45 | 211.13 | 152.19 | 187.53 | 481,491 | -23.87 | -12.53% |
| 6 Months | 123.80 | 211.13 | 110.45 | 172.52 | 586,731 | 42.78 | 34.56% |
| 1 Year | 149.06 | 211.13 | 110.45 | 165.44 | 583,920 | 17.52 | 11.75% |
| 3 Years | 218.42 | 327.32 | 110.45 | 186.57 | 520,138 | -51.84 | -23.73% |
| 5 Years | 60.27 | 327.32 | 57.25 | 161.16 | 508,801 | 106.31 | 176.39% |
Repligen Description
| Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. |
